Epirubicin, Cisplatin, and Fluorouracil (ECF) Regimen

doi:10.1310/hpj4412-1072

Verified recordOpen access

Epirubicin, Cisplatin, and Fluorouracil (ECF) Regimen

Hospital Pharmacy2009doi:10.1310/hpj4412-1072

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Authors

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

Unresolved referenced work

1992

10.1016/0959-8049(94)90198-8

10.1002/bjs.1800811218

10.1002/1097-0142(19951115)76:103.0.co;2-k

10.1002/1097-0142(19951115)76:10<1694::aid-cncr2820761004>3.0.co;2-k

Unresolved referenced work

1996

10.1002/(sici)1097-0142(19981215)83:123.3.co;2-8

10.1002/(sici)1097-0142(19981215)83:12<2475::aid-cncr10>3.3.co;2-8

10.1038/sj.bjc.6690350

10.1177/030089169908500404

10.1177/030089160108700105

10.3346/jkms.2002.17.3.348

10.1200/jco.2005.02.163

Epirubicin, Cisplatin, and Fluorouracil (ECF) Regimen

Referenced works

Cited by

External reference records

Additional external references